Bariatric or metabolic surgery is increasingly used as an adjunct to the treatment
of diabetes. Many studies have demonstrated surgery to be superior to medical management.
However, many programs require that patients meet a target hemoglobin A1c (Hgb A1c)
level. As a result, some patients are denied surgery due to an inability to achieve
an arbitrary Hgb A1c level. We sought to understand the impact of preoperative A1c
levels on perioperative outcomes, including diabetes resolution and weight loss.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Surgery for Obesity and Related DiseasesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2015 Published by Elsevier Inc.
